ATEA PHARMACEUTICALS INC (AVIR) Stock Income Statement
NASDAQ:AVIR - Nasdaq - US04683R1068 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 351.40M | |||
| Operating Expenses | 140.04M | 132.00M | 120.00M | 111.20M | 119.50M | |||
| Research and Development | 93.39M | N/A | 70.09M | 62.40M | 73.70M | |||
| Selling, General, and Administrative Expenses | 45.85M | 49.00M | 50.00M | 48.70M | 45.80M | |||
| Operating Income | -140.04M | -132.00M | -120.00M | -111.20M | 231.90M | |||
| Interest Income/Expense | 23.59M | N/A | 29.22M | 11.20M | 200.00K | |||
| Other Income/Expense | N/A | 26.00M | N/A | N/A | N/A | |||
| Non Recurring Items | -22.23M | -61.00M | -44.00M | -19.50M | -93.50M | |||
| Income Before Taxes | -138.31M | -167.00M | -135.00M | -119.50M | 138.60M | |||
| Income Tax | 894.00K | 930.00K | 1.02M | -3.60M | 17.40M | |||
| Net Income | -139.97M | -168.00M | -136.00M | -115.90M | 121.20M | |||
| EBITDA | -139.62M | -131.58M | -119.58M | -110.90M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.65 | -2.00 | -1.63 | -1.39 | 1.37 | |||
| Non GAAP EPS | -1.65 | -2.00 | -1.64 | -1.40 | 1.36 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | 34.49% | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | 65.99% | |||
All data in USD